Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ainos Inc AIMD

Healthcare Biotechnology
Ainos, Inc. is engaged in developing medical technologies for point-of-care (POCT) testing and medical treatment for a range of disease indications. The Company is engaged in the research and clinical development activities for its programs, securing related intellectual property, and commercializing therapeutics using low-dose non-injectable interferon (IFN). Its Medtech solutions includes... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AIMD)

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Accesswire 12 days ago

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Accesswire November 11, 2024

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Accesswire November 8, 2024

Ainos Reports Third Quarter 2024 Financial Results

Accesswire November 6, 2024

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Accesswire October 28, 2024

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Accesswire October 24, 2024

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Accesswire October 7, 2024

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Accesswire September 25, 2024

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Accesswire September 24, 2024
View More News ››

Opinion & Analysis (NDAQ:AIMD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AIMD)

$AIMD #Veldona #AinosInc

Apple:https://podcasts.apple.com/podcast/id1693448305 Spotify:https://open.spotify.com/show/65HhA2UPZVDW55kA3sCkXh
CashSeeker - 4 days ago

$AIMD Analyst Coverage

https://ir.ainos.com/analyst-coverage
CashSeeker - 5 days ago

$AIMD Interview

$AIMD Tune in to WTR Small-Cap Spotlight with WTR's Do Kim and Jack Lu from @AinosInc on Veldona's therapeutic...
CashSeeker - 6 days ago

$AIMD Flora Powerful & Discreet Detection in your hand

 https://www.ainos.com/ainosflora.html
CashSeeker - 7 days ago

$AIMD -

 Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel...
CashSeeker - 7 days ago

AIMD news out!

Exciting news! Ainos has received IRB approval for its Sjgren’s Syndrome clinical study at Shuang Ho Hospital, Taipei Medical University...
mlnman - 13 days ago
View more Bullboard ››

Fiddlehead Resources Corp.

Fiddlehead Resources Corp.

Fiddlehead Resources Corp. is a TSXV listed Cardium-focused oil and gas producer with 1,750 boepd of low decline, high ...
View More »